BioMaxima S.A. (FRA:944)

Market Cap	12.26M -21.3%
Revenue (ttm)	13.85M +17.5%
Net Income	152.10K
EPS	0.04
Shares Out	n/a
PE Ratio	80.61
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	2.530
Previous Close	2.480
Day's Range	2.480 - 2.530
52-Week Range	2.170 - 3.060
Beta	n/a
RSI	41.39
Earnings Date	Apr 30, 2026

About BioMaxima

BioMaxima S.A. produces and distributes microbiological media, reagents, and in vitro diagnostic equipment in Poland. It offers microbiology products, including ready to use media, such as plates, bottles, bags, and media in tubes; dehydrated media; agars and peptones; and supplements. The company also provides molecular biology and cell culture products which includes real time PCR, nucleic acid isolation, NA and PCR electrophoresis, protein electrophoresis, enzymes, antibiotics, agaroses and molecular biology media, media and buffers for in v...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1997
• Employees: 135
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 944

Financial Performance

In 2024, BioMaxima's revenue was 52.85 million, an increase of 12.96% compared to the previous year's 46.79 million. Earnings were 535,000, a decrease of -8.70%.

Financial numbers in PLN